脂肪族二酸二烷基双去氢枞基双噁二唑的合成及除草活性

以去氢枞酸为原料,制备去氢枞酸酰氯.以脂肪族二酸为原料,经过脂肪族二酸二乙酯得到脂肪族二酸二酰肼.脂肪族二酸二酰肼与去氧枞酸酰氯在相转移催化下反应得到N,N＇-二去氢枞酰基取代脂肪族二酸二酰肼,再脱水环合,得到5个标题化合物脂肪族二酸二烷基双去氢枞基双噁二唑.通过元素分析,IR,MS,1H NMR和13C NMR对所合成的新化合物进行了结构表征.初步的除草活性测试表明,化合物6b～6e在100 μg/mL浓度下对油菜的胚根生长具有良好的抑制作用,抑制率均超过80％.     

去氢枞醇杂环类化合物的合成及细胞毒性研究

以去氢枞酸(1)为原料,经氢化铝锂还原得到去氢枞醇(2),2与氯乙酰氯在氮气保护和DMAP催化条件下反应合成中间产物去氢枞醇氯乙酸酯(3),3与杂环化合物经亲核取代反应合成了12个新型去氢枞醇杂环类化合物(4a ～41).利用IR、1H NMR、13C NMR和HR-MS等对目标化合物的结构进行表征,采用MTT法测试目...     

新型去氢枞酸基磺酰胺类化合物的合成及其生物活性

去氢枞酸与SOCl2反应制得去氢枞酸酰氯(2);芳磺酰氯与乙二胺经N-酰化反应制得N-芳磺酰基乙二胺(4a~4k);在DMAP催化下,2分别与4a~4k经N-酰化反应合成了11个新型的去氢枞酸基磺酰胺类化合物(5a~5k),其结构经1H NMR,13C NMR,IR和ESI-MS表征。生物活性测试结果表明,在用药量为50μg·mL-1时,5a~5k对黄瓜枯萎病菌、苹果轮纹病菌、番茄早疫病菌、花生褐斑病菌和小麦赤霉病菌有一定的抑菌活性,其中去氢枞酸基间甲基苯磺酰胺(5c)对番茄早疫病菌的杀菌活性最佳,抑制率为73.6%;在用药量为100μg·mL-1时,大部分化合物对油菜的胚根生长有一定抑制作用,其中去氢枞酸基对甲氧基苯磺酰胺(5d)的抑菌活性最佳,抑菌率为57.1%。     

苯乙酮类去氢枞酰腙的合成

以去氢枞酸为原料,经三氯化磷酰氯化得到去氢枞酰氯(2);2与85%水合肼反应合成了去氢枞酰肼(3);3再分别与苯乙酮及其衍生物发生缩合反应得到4个新型的苯乙酮类去氢枞酰腙化合物,其结构经UV,1H NMR和IR表征.     

2-取代酰氨基-5-去氢枞基-1,3,4-噻二唑衍生物的合成及杀菌活性

为了寻找具有更高生物活性的新颖先导化合物,本文以去氢枞酸为原料,设计并合成了11个具有1,3,4-噻二唑骨架的新型去氢枞酸衍生物,通过1H NMR、13C NMR、IR、EI-MS和元素分析确认了目标产物的结构。初步的生物活性测试结果表明,大部分化合物具有一定的杀菌活性,其中,化合物2在浓度为50mg/L时对番茄早疫病菌的抑制率达88.9%。     

1-苯基-5-芳基-1,2-二氢-1,2,4-三唑-3-硫酮的合成

将取代苯甲酰氯1a～1f与硫氰酸钾反应, 得到的中间体不需纯化直接与苯肼反应, 成功地合成了1-苯基-5-芳 基-1,2-二氢-1,2,4-三唑-3-硫酮(2a～2f). 化合物2的结构通过红外光谱、核磁共振光谱和高分辨质谱进行了表征.     

超声法合成新型3-(5-氯/苯氧基-3-甲基-1-苯基-4-吡唑基)异噁唑N-取代苯基去甲去氢斑蝥酰亚胺衍生物

去甲去氢斑蝥素与取代芳胺反应得到了一系列N-取代苯基去甲去氢斑蝥酰亚胺, 再与5-氯/苯氧基-4-(α-氯-α-肟基甲基)-3-甲基-1-苯基吡唑甲酰基氯代肟发生1,3-偶极环加成反应生成一系列未见报道的3-(5-氯/苯氧基-3-甲基-1-苯基-4-吡唑基)异噁唑N-取代苯基去甲去氢斑蝥酰亚胺衍生物. 所合成化合物经元素分析, IR, ¹H NMR, ¹H-¹HCOSY, NOESY确证结构.     

N-(4-取代苯基-噻唑-2-基)香豆素类亚胺化合物的合成及抑菌活性研究

由含不同取代基的水杨醛与乙酰乙酸乙酯在哌啶存在下反应,得到乙酰基香豆素中间体,再与氨基硫脲缩合,得到含香豆素基的缩氨基硫脲化合物,继而与a-溴代芳基酮发生缩合反应,合成了9个未见报道的新的N-(4-取代苯基-噻唑-2-基)香豆素类亚胺化合物,其结构用IR,1HNMR和HRMS进行了确证,初步生物活性测定实验证明部分目标化合物具有良好的抑菌活性.     

1-叔丁胺基-3-[(5-苯基-1,3,4-噻二唑-2-基)氧]-2-丙醇顺丁烯二酸盐的合成研究

以硫代氨基脲为起始原料,通过缩合、环化、取代等反应合成了1-叔丁胺基-3-[(5-苯基-1,3,4-噻二唑-2-基)氧]-2-丙醇顺丁烯二酸盐.所得中间体及目标化合物结构经测定熔点、热重分析、红外光谱、质谱和核磁共振氢谱等得到确认.     

硫化氢供体型去氢枞酸衍生物的合成及其细胞毒性

以去氢枞酸为原料,通过不同的长度碳链与硫化氢供体4-羟基硫代苯甲酰胺偶联,合成了5个新型硫化氢供体型去氢枞酸衍生物,所得化合物结构经¹H NMR、 ¹³C NMR和HR-MS表征。以阿霉素为阳性对照药,采用MTT法测定目标化合物对HepG2、 MGC803、 T24、 A549和LO2的细胞抑制作用。结果表明：大部分化合物对4种肿瘤细胞株的抑制活性优于母体化合物去氢枞酸,其中化合物4c对HepG2、 T24和A549细胞株的IC50值分别为4.63±0.18、 6.06±0.49和5.79±0.14 μmol·L^-1,优于或接近阳性对照药阿霉素（5.44±0.87、 3.69±0.78和3.75±0.11μmol·L^-1）。     

1-脱氢松香酰基-3-取代硫脲以及5-(脱羧脱氢松香-4-基)-3-芳氨基- 1H-1,2,4-三唑化合物的合成与生物活性

以广西的优势资源松香为原料, 脱氢松香酸与亚硫酰氯、硫氰化钾分别在回流条件下反应6 h和1.5 h, 得到脱氢松香酰异硫氰酸酯, 产率52%; 然后与胺在加热回流条件下反应1.5 h, 得到11种1-脱氢松香酰基-3-取代硫脲4, 产率63%～94%; 4a～4f 分别与水合肼在搅拌下回流反应3～6 h, 得到6种5-(脱羧脱氢松香-4-基)-3-芳氨基-1H-1,2,4-三唑化合物5, 产率70%～94%; 所有化合物的结构均经IR, 1H NMR, 13C NMR和元素分析确认. 初步生物活性测试表明, 4e, 4f, 4j, 5b对枯草杆菌抑菌率较高, 特别是4j在浓度为50 mg/L时就达到较好效果; 4b, 4h, 4i, 5e在100 mg/L时对大肠杆菌的抑菌效果较好.     

5-取代吲哚-2-酮的合成

4-取代苯胺依次与水合氯醛及盐酸羟胺反应制得4-取代异亚硝基乙酰苯胺(2a～2e);2在浓硫酸作用下环合制得5-取代靛红(3a～3e);3通过改进的Wolff-Kishner-黄鸣龙反应合成了重要的药物中间体——5-取代吲哚-2-酮(5a～5e);5a通过硝化制得5-硝基吲哚-2-酮(5f);5f被还原制得5-氨基吲哚-2-酮(5g)。其结构经1H NMR和MS确证。     

ATRP法合成聚去氢枞酸丙烯酸乙二醇酯的研究

本研究从歧化松香中提取的去氢枞酸(DHA)出发,经酰氯化后与丙烯酸(2-羟基)乙酯反应,合成了去氢枞酸丙烯酸乙二醇酯(DHAAGE);并以此为单体,2-溴-异丁酸乙酯(EBr-iB)为引发剂,CuBr/2,2'-联吡啶(2,2'-bipyridine)为催化体系,在90 oC下,利用原子转移聚合(ATRP)法制备了聚去氢枞酸丙烯酸乙二醇酯(PDHAAGE).利用FT-IR、1H-NMR和GPC对所制备的单体和聚合物进行了表征,同时考察了单体转化率随聚合反应时间的变化.结果表明,聚合反应动力学曲线呈良好线性关系,表观聚合速率常数kp′为3.6 ×10-7 s-1;所得聚合物的分子量分布很窄.     

Synthesis, Reactions, and Anti-arrhythmic activity of Substituted Heterocyclic Systems Using 5-Chloroanisic Acid as Starting Material

Summary. A series of substituted heterocyclic systems were prepared from N1-[4-(4-fluorocinnamoyl)phenyl]-5-chloro-2-methoxybenzamide, which was prepared from the corresponding 5-chloroanisic acid (2-methoxy-4-chlorobenzoic acid) as starting material. Treating of the cinnamoyl derivative with hydrazine hydrate in dioxane afforded a pyrazoline, which was reacted with morpholine and paraformaldehyde to give the N-substituted pyrazoline. Acylation of pyrazoline with acetyl chloride in dioxane afforded the N-acetyl analogue. Also, the cinamoyl derivative was reacted with methylhydrazine, phenylhydrazine, or ethyl cyanoacetate to yield the corresponding N-methyl-, N-phenylpyrazoline, pyrane, and pyridone derivatives. Condensation of the cinnamoyl derivative with cyanothioacetamide gave the pyridinethione derivative, which was treated with ethyl chloroacetate affording the ethyl carboxylate derivative. Also, it was reacted with malononitrile or ethyl acetoacetae to give the cyano amino analougues and ethyl carboxylate, which was reacted with methylhydrazine to give the (indazolyl)phenyl derivative. On the other hand, reaction of cinnamoyl derivative with acetyl acetone afforded the cyclohexenyl derivative, which was reacted with hydrazine hydrate to give the [methylindazolyl]phenyl derivative. Condensation of the cinnamoyl derivative with guanidine hydrochloride or thiourea afforded the aminopyrimidine derivative and thioxopyrimidine. The latter was condensed with chloroacetic acid to yield a thiazolopyrimidine, which was condensed with 2-thiophenealdehyde to yield the arylmethylene derivative, however, it was also prepared directly from thiopyrimidine by the action of chloroacetic acid, 2-thiophenealdehyde, and anhydrous sodium acetate. The pharmacological screening showed that many of these compounds have good anti-arrhythmic activity and low toxicity.     

Synthesis of N-Aryl-2- (1'' , 6'' -dihydro-6'' -pyridazinone-3''-carbonyl) Thiosemicarbazides and Their Related Heterocyclic Compounds

1,6-Dihydro-3-hydrozinocarbonyl-6-pyridazinone(compound 2) were prepared from α-ketoglutaric acid and hydrazine hydrate. A series of N-aryl-2-(1' ,6'-dihydro-6'-pyridazinone-3'-earbonyl) thiosemicarbazides 3a-3f were synthesized from the reaction of aryl isothiocyanates with compound 2. The terminal compounds 1,3, 4-thiadiazole, 1,3,4-oxadiazole and 1,2, 4-triazol-5-thione derivatives were cyclized from compounds 3a-3f. Their structures were confirmed by IR, 1H NMR, MS and elemental analyses.     

Synthesis of N-Aryl-2- （1＇, 6＇-dihydro-6＇-pyridazinone-3＇-carbonyl） Thiosemicarbazides and Their Related Heterocyclic Compounds

1,6-Dihydro-3-hydrozinocarbonyl-6-pyridazinone (compound 2) were prepared from α-ketoglutaric acid and hydrazine hydrate. A series of N-aryl-2-(1‘,6‘-dihydro-6‘-pyridazinone-3‘-carbonyl) thiosemicarbazides 3a-3f were synthesized from the reaction of aryl isothiocyanates with compound 2. The terminal compounds 1,3, 4-thiadiazole, 1,3,4-oxadiazole and 1,2, 4-triazol-5-thione derivatives were cyclized from compounds 3a-3f. Their structures were confirmed by IR,^1H NMR, MS and elemental analyses.     

Syntheses of substituted-oxazolo-1,3,4-thiadiazoles, 1,3,4-oxadiazoles,and 1,2,4-triazoles

Starting from readily available methyl 5-methyloxazole-4-carboxylate ( 1 ) and 4-methyl-5-oxazolylcar-boxylic acid hydrazide ( 11 ) the title compounds were prepared. The reaction of compound 1 with hydrazine hydrate afforded the corresponding hydrazide 2 . The reaction of compound 2 with formic acid yielded 1-formyl-2-(5-methyloxazole-4-carboxyl)hydrazine ( 3 ). Refluxing of the latter with phosphorus pentasulfide in xylene gave compound 5 in 62% yield. The reaction of compound 3 with phosphorus pentoxide afforded compound 4 . Starting from hydrazide 11 , compounds 13 and 14 were prepared similarly. Reaction of compound 2 with substituted isothiocyanate yielded compound 9 which was cyclized in basic medium to 4-alkyl-5-(5-methyl-4-oxazolyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione ( 10 ). The isomer 19 was prepared similarly. Methylation and subsequent oxidation of compound 19 gave compound 21 . Reaction of the acid 7 with thiosemicarbazide in the presence of phosphorus oxychloride gave 2-amino-5-(5-methyl-4-oxazolyl)1,3,4-thiadiazole ( 8 ). 2-Amino-5-(4-methyl-5-oxazolyl)-1,3,4-thiadiazole ( 17 ) was prepared from acyl chloride 15 by the usual method.     

4,5-Dihydropyrazolo[3,4-f]quinazolines

By reaction of 6-dimethylamino-5-oxo-2-phenyl-5,6,7,8-tetrahydroquinazoline with hydrazine, phenylhydrazine, 4-bromo-, 4-chlorophenylhydrazines, and also reaction of 6-dimethylaminomethylene-5-oxo-2-(4-pyridyl)-5,6,7,8-tetrahydroquinazoline with hydrazine, 4-methoxy- and 2-carboxyphenylhydrazines, we have obtained the corresponding 7-phenyl(4-pyridyl)-substituted 1H(2H)- or 1-aryl-4,5-dihydropyrazolo[3,4-f]quinazolines. Methylation of 7-phenyl-4,5-dihydro-1(2H)-pyrazolo[3,4-f]quinazoline by methyl iodide led to its 2-methyl derivative.     

对位取代酚亚甲基桥三聚物的合成

本文报道通过2, 6-二羟甲基对取代酚和合适的对取代酚的缩合制备一系列对取代酚亚甲基桥三聚物的方法。产率一般为50%左右。